Metoclopramide Accord

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Accord, is a dopamine antagonist (antiemetic, gastro‑prokinetic) presented as an oral dosage form for oral use. It is employed to control nausea, vomiting and to improve gastric emptying in a variety of clinical settings. GNH USA supplies Metoclopramide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide Accord acts on dopamine pathways to manage several gastrointestinal and emetic conditions. - Nausea and vomiting: reduces episodes by blocking dopamine receptors in the chemoreceptor trigger zone. - Post‑operative nausea and vomiting: prevents and treats nausea after surgical procedures. - Chemotherapy‑induced nausea and vomiting: mitigates emesis associated with cytotoxic drugs. - Gastroparesis: accelerates gastric emptying and improves stomach motility. - Gastro‑oesophageal reflux disease (GERD) adjunct: enhances reflux control when used with standard therapy.

Metoclopramide may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild sedation occurring shortly after dosing. - Restlessness or akathisia: feeling of inner tension or inability to stay still. - Diarrhea: loose stools due to increased GI motility. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Tardive dyskinesia: irreversible involuntary movements with prolonged use. - Neuroleptic malignant syndrome: life‑threatening hyperthermia and muscle rigidity. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Monitor for extrapyramidal symptoms: watch for involuntary movements or rigidity. - Avoid in patients with known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in pregnancy: limited data, benefits must outweigh potential risks. - Store at room temperature: keep in the original container, protect from moisture and light.

Metoclopramide can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine blockade may worsen extrapyramidal effects. - CYP2D6 inhibitors (e.g., fluoxetine): increase metoclopramide plasma concentrations. - Anticholinergic agents: may mask early signs of extrapyramidal reactions.

Moderate Interactions (Monitor Closely): - Opioids: may enhance anti‑nausea benefit but increase sedation risk. - Macrolide antibiotics (e.g., erythromycin): synergistic increase in gastrointestinal motility. - Diuretics: potential for electrolyte disturbances when combined with increased GI activity.